Sage Therapeutics (NASDAQ:SAGE) Now Covered by Analysts at Bank of America
Bank of America started coverage on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a report released on Tuesday. The brokerage issued an underperform rating and a $5.00 target price on the biopharmaceutical company’s stock. Other research analysts also recently issued reports about the stock. TD Cowen lowered their price objective on shares of […]
Bank of America started coverage on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a report released on Tuesday. The brokerage issued an underperform rating and a $5.00 target price on the biopharmaceutical company’s stock. Other research analysts also recently issued reports about the stock. TD Cowen lowered their price objective on shares of […]
